Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;118:1748-1757
Published online before print October 6, 2008, doi: 10.1161/CIRCULATIONAHA.108.783738
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
118/17/1748    most recent
CIRCULATIONAHA.108.783738v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shroff, R. C.
Right arrow Articles by Shanahan, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shroff, R. C.
Right arrow Articles by Shanahan, C. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
Medline Plus Health Information
*Dialysis
*Kidney Failure
*Vascular Diseases
Related Collections
Right arrow Apoptosis
Right arrow Cell biology/structural biology
Right arrow Other arteriosclerosis
Right arrow Smooth muscle proliferation and differentiation
Right arrow Mechanism of atherosclerosis/growth factors
Right arrow Other Vascular biology
Right arrowRelated Article

(Circulation. 2008;118:1748-1757.)
© 2008 American Heart Association, Inc.


Vascular Medicine

Dialysis Accelerates Medial Vascular Calcification in Part by Triggering Smooth Muscle Cell Apoptosis

Rukshana C. Shroff, MRCPCH; Rosamund McNair; Nichola Figg; Jeremy N. Skepper, PhD; Leon Schurgers, PhD; Ashmeet Gupta, MRCPCH; Melanie Hiorns, FRCR; Ann E. Donald, PhD; John Deanfield, FRCP; Lesley Rees, FRCPCH; Catherine M. Shanahan, PhD

From the Nephrology (R.C.S., A.G., L.R.), Radiology (M.H.), and Vascular Physiology (A.E.D., J.D.) Units, Great Ormond Street Hospital and University College London Institute of Child Health; BHF Centre, Cardiovascular Division, King’s College London (R.C.S., C.M.S.), London; Department of Medicine, Addenbrooke’s Hospital (R.M., N.F.); Multi-Imaging Centre, Department of Anatomy (J.N.S.), Cambridge, United Kingdom; and CARIM and VitaK (L.S.), University of Maastricht, Maastricht, The Netherlands.

Correspondence to Catherine Shanahan, PhD, BHF Centre, BHF Senior Fellow and Professor of Cellular Signalling, Cardiovascular Division, 125 Coldharbour Lane, King’s College London, London SE5 9NU. E-mail cathy.shanahan{at}kcl.ac.uk

Received April 3, 2008; accepted August 14, 2008.

Background— Vascular calcification is associated with increased morbidity and mortality in stage V chronic kidney disease, yet its early pathogenesis and initiating mechanisms in vivo remain poorly understood. To address this, we quantified the calcium (Ca) load in arteries from children (10 predialysis, 24 dialysis) and correlated it with clinical, biochemical, and vascular measures.

Methods and Results— Vessel Ca load was significantly elevated in both predialysis and dialysis and was correlated with the patients’ mean serum Caxphosphate product. However, only dialysis patients showed increased carotid intima-media thickness and increased aortic stiffness, and calcification on computed tomography was present in only the 2 patients with the highest Ca loads. Importantly, predialysis vessels appeared histologically intact, whereas dialysis vessels exhibited evidence of extensive vascular smooth muscle cell (VSMC) loss owing to apoptosis. Dialysis vessels also showed increased alkaline phosphatase activity and Runx2 and osterix expression, indicative of VSMC osteogenic transformation. Deposition of the vesicle membrane marker annexin VI and vesicle component mineralization inhibitors fetuin-A and matrix Gla-protein increased in dialysis vessels and preceded von Kossa positive overt calcification. Electron microscopy showed hydroxyapatite nanocrystals within vesicles released from damaged/dead VSMCs, indicative of their role in initiating calcification.

Conclusions— Taken together, this study shows that Ca accumulation begins predialysis, but it is the induction of VSMC apoptosis in dialysis that is the key event in disabling VSMC defense mechanisms and leading to overt calcification, eventually with clinically detectable vascular damage. Thus the identification of factors that lead to VSMC death in dialysis will be of prime importance in preventing vascular calcification.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2008 118: 1689-1690. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
N. Koleganova, G. Piecha, E. Ritz, P. Schirmacher, A. Muller, H.-P. Meyer, and M.-L. Gross
Arterial calcification in patients with chronic kidney disease
Nephrol. Dial. Transplant., March 27, 2009; (2009) gfp137v1.
[Abstract] [Full Text] [PDF]